[go: up one dir, main page]

EE200000538A - TNF/NGF retseptoriperekonna retseptorite ja muudevalkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon - Google Patents

TNF/NGF retseptoriperekonna retseptorite ja muudevalkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon

Info

Publication number
EE200000538A
EE200000538A EEP200000538A EEP200000538A EE200000538A EE 200000538 A EE200000538 A EE 200000538A EE P200000538 A EEP200000538 A EE P200000538A EE P200000538 A EEP200000538 A EE P200000538A EE 200000538 A EE200000538 A EE 200000538A
Authority
EE
Estonia
Prior art keywords
tnf
modulators
functioning
proteins
preparation
Prior art date
Application number
EEP200000538A
Other languages
English (en)
Estonian (et)
Inventor
Wallach David
Kovalenko Andrei
S. Horwitz Marshall
Li Yongan
Original Assignee
Yeda Research And Development Co. Ltd.
Albert Einstein College Of Medicine Of Yeshiva University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12375898A external-priority patent/IL123758A0/xx
Application filed by Yeda Research And Development Co. Ltd., Albert Einstein College Of Medicine Of Yeshiva University filed Critical Yeda Research And Development Co. Ltd.
Priority to EEP200900055A priority Critical patent/EE200900055A/xx
Publication of EE200000538A publication Critical patent/EE200000538A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200000538A 1998-03-19 1999-03-18 TNF/NGF retseptoriperekonna retseptorite ja muudevalkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon EE200000538A (et)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EEP200900055A EE200900055A (et) 1998-03-19 1999-03-18 TNF/NFG retseptoriperekonna retseptorite ja muude valkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL12375898A IL123758A0 (en) 1998-03-19 1998-03-19 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins
IL12602498A IL126024A0 (en) 1998-03-19 1998-09-01 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
PCT/IL1999/000158 WO1999047672A1 (en) 1998-03-19 1999-03-18 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
CA002323637A CA2323637A1 (en) 1998-03-19 1999-03-18 Modulators of the function of receptors of the tnf/ngf receptor family and other proteins

Publications (1)

Publication Number Publication Date
EE200000538A true EE200000538A (et) 2002-04-15

Family

ID=39598416

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000538A EE200000538A (et) 1998-03-19 1999-03-18 TNF/NGF retseptoriperekonna retseptorite ja muudevalkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon

Country Status (24)

Country Link
US (1) US6734174B1 (zh)
EP (1) EP1062336B1 (zh)
JP (1) JP4351389B2 (zh)
KR (1) KR100748293B1 (zh)
CN (1) CN1232641C (zh)
AT (1) ATE318310T1 (zh)
AU (1) AU760900B2 (zh)
BG (2) BG64990B1 (zh)
BR (1) BR9909659A (zh)
CA (2) CA2625284A1 (zh)
DE (1) DE69929958T2 (zh)
DK (1) DK1062336T3 (zh)
EA (1) EA004062B1 (zh)
EE (1) EE200000538A (zh)
ES (1) ES2258838T3 (zh)
HK (1) HK1034995A1 (zh)
HU (1) HUP0101612A3 (zh)
IL (1) IL126024A0 (zh)
NO (1) NO327854B1 (zh)
NZ (2) NZ525566A (zh)
PL (1) PL200763B1 (zh)
PT (1) PT1062336E (zh)
SK (1) SK285804B6 (zh)
WO (1) WO1999047672A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189832B1 (en) * 1998-08-20 2007-03-13 The Regents Of The University Of California Gamma subunit of cytokine responsive IκB-alpha kinase complex and methods of using same
US7745579B1 (en) 1998-09-01 2010-06-29 David Wallach Inhibitor of NF-KB activation
DK2270052T3 (en) 2001-06-26 2018-07-02 Amgen Inc Antibodies to OPGL
US7521534B1 (en) * 2003-03-03 2009-04-21 The University Board Of Regents Of Texas System IKK gamma gene products and methods for making and using same
BRPI0414714A (pt) * 2003-09-24 2006-11-21 Pasteur Institut polinucleotìdeo purificado, vetor, célula hospedeira, construto de fusão de polipeptìdeo, métodos de inibir a rota de sinalização de nf-capab, de interromper a oligomerização de nemo, e, de identificar polipeptìdeos que modulam a oligomerização de nemo, e, uso de uma quantidade eficaz de uma composição
EP2492281B1 (en) 2009-10-19 2018-04-11 HanAll Biopharma Co., Ltd. Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
CN102399819B (zh) * 2011-08-24 2013-06-19 西北农林科技大学 一种质粒型腺病毒载体pAd-NRIP1及其构建方法
DE102011115480A1 (de) * 2011-10-06 2013-04-11 Biostep Gmbh Substrat und Vorrichtung zur Chemilumineszenzdetektion
SG11201704764PA (en) 2014-12-11 2017-07-28 Harvard College Inhibitors of cellular necrosis and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
IL94039A (en) * 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
EP0398327B2 (en) * 1989-05-18 2013-02-20 Yeda Research And Development Co., Ltd. Tumor necrosis factor binding protein II, its purification and antibodies thereto
WO1996025941A1 (en) * 1995-02-22 1996-08-29 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein
AU7457796A (en) * 1995-10-23 1997-05-15 Tularik Inc. Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays
EP0914338A2 (en) * 1996-05-29 1999-05-12 Genzyme Corporation Cell growth regulatory genes

Also Published As

Publication number Publication date
WO1999047672A1 (en) 1999-09-23
EA200000961A1 (ru) 2001-04-23
PT1062336E (pt) 2006-05-31
HUP0101612A2 (hu) 2004-01-28
IL126024A0 (en) 1999-05-09
DE69929958T2 (de) 2006-11-23
BG109537A (en) 2007-11-30
JP2002506644A (ja) 2002-03-05
BG104769A (en) 2001-04-30
JP4351389B2 (ja) 2009-10-28
CA2323637A1 (en) 1999-09-23
AU760900B2 (en) 2003-05-22
ES2258838T3 (es) 2006-09-01
EP1062336A1 (en) 2000-12-27
PL200763B1 (pl) 2009-02-27
CN1232641C (zh) 2005-12-21
HK1034995A1 (en) 2001-11-09
PL343262A1 (en) 2001-07-30
HUP0101612A3 (en) 2005-03-29
NZ506776A (en) 2003-08-29
NO20004649D0 (no) 2000-09-18
KR20050107527A (ko) 2005-11-11
DE69929958D1 (de) 2006-04-27
ATE318310T1 (de) 2006-03-15
SK285804B6 (sk) 2007-08-02
BG64990B1 (bg) 2006-11-30
KR100748293B1 (ko) 2007-08-09
AU2954599A (en) 1999-10-11
NZ525566A (en) 2004-12-24
SK13762000A3 (sk) 2001-03-12
CA2625284A1 (en) 1999-09-23
EP1062336B1 (en) 2006-02-22
CN1295614A (zh) 2001-05-16
US6734174B1 (en) 2004-05-11
BG65684B1 (bg) 2009-06-30
DK1062336T3 (da) 2006-05-29
NO327854B1 (no) 2009-10-05
EA004062B1 (ru) 2003-12-25
BR9909659A (pt) 2000-11-21
NO20004649L (no) 2000-10-30

Similar Documents

Publication Publication Date Title
HUP9902952A1 (hu) Ionos komplex formájú, vízoldható gyógyászati készítmény és alkalmazása
ATE240315T1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
EE200000538A (et) TNF/NGF retseptoriperekonna retseptorite ja muudevalkude talitluse modulaatorid, nende valmistamine ja kasutamine ning farmatseutiline kompositsioon
DE69937573D1 (de) Extrazelluläres, neues rage-bindendes protein (en-rage) und dessen verwendungen
TR199900903T2 (xx) Bir t�m�r nekroz fakt�r� ailesine ili�kin protein
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
ATE223701T1 (de) Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen
BR0304963A (pt) Compostos, composição farmacêutica, e, métodos para modular a atividade de adenosina em um mamìfero, e para tratar um mamìfero sofrendo de ou suscetìvel às doenças
EP0800828A4 (en) TRANSMUCOSAL PREPARATION
ATE302215T1 (de) Modulatoren von intrazellulären entzündungs-, zelltod- und zellüberlebenswegen, die card- und kinase-domänen enthalten
EA199900842A1 (ru) Модуляторы функции рецепторов, принадлежащих к семейству рецепторов tnf/ngf
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
ES2164169T3 (es) Proteinas estimulantes de celulas t de pestivirus.
SG148025A1 (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
DK0852623T3 (da) Nukleinsyremolekyler kodende for proteiner, som medierer adhæsionen af Neisseria-celler til humane celler
NO990322L (no) Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist
DE69821227D1 (de) Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen
FI971872A0 (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
ATE397663T1 (de) Humane ltrpc7 proteine, dafür kodierende nukleinsäuren und deren verwendungen
UA72877C2 (en) Modulators of metabolic ways of intracellular inflammation, cells death and survival
DE60225530D1 (de) Phosphorylierte glyoxalase i und deren verwendung
DK1019500T3 (da) IFN receptor 1-bindende proteiner, DNA, som koder for dem, og fremgangsmåder til modulering af cellulært respons på interferoner
SI1007672T1 (sl) Znotrajcelični modulatorji Apoptotske celične smrti na osnovi levcinskih zadrg, ki so inducirani z glukokortikoidi
DE60128252D1 (de) Membranfraktionen von mit 1,2-sn-Diacylglycerol angereicherten Zellen
UY24489A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimiento para su preparación y aplicación de estos compuestos en medicamentos.